Logan Capital Management’s Warner Bros WBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,655
Closed -$32.3K 472
2025
Q3
$32.3K Hold
1,655
﹤0.01% 322
2025
Q2
$19K Sell
1,655
-3,275
-66% -$30.5K ﹤0.01% 333
2025
Q1
$52.8K Sell
4,930
-12
-0.2% -$126 ﹤0.01% 338
2024
Q4
$52.2K Sell
4,942
-337
-6% -$3.13K ﹤0.01% 342
2024
Q3
$43.5K Hold
5,279
﹤0.01% 347
2024
Q2
$39.3K Sell
5,279
-407
-7% -$3.26K ﹤0.01% 350
2024
Q1
$49.7K Sell
5,686
-52,664
-90% -$508K ﹤0.01% 340
2023
Q4
$665K Sell
58,350
-308
-0.5% -$3.33K 0.03% 234
2023
Q3
$636K Sell
58,658
-457
-0.8% -$5.7K 0.03% 231
2023
Q2
$741K Sell
59,115
-986
-2% -$12.8K 0.04% 228
2023
Q1
$908K Sell
60,101
-1,526
-2% -$21.7K 0.04% 229
2022
Q4
$585K Sell
61,627
-1,380
-2% -$15.6K 0.03% 240
2022
Q3
$724K Sell
63,007
-8,434
-12% -$115K 0.04% 225
2022
Q2
$959K Buy
+71,441
New +$1.33M 0.06% 211
2022
Q1
Sell
-330
Closed -$8K 553
2021
Q4
$8K Hold
330
﹤0.01% 471
2021
Q3
$8K Hold
330
﹤0.01% 466
2021
Q2
$10K Hold
330
﹤0.01% 454
2021
Q1
$14K Buy
+330
New +$16.5K ﹤0.01% 417

Other funds holding WBD

Logan Capital Management's WBD Position: Q4 2025 in Review

Logan Capital Management sold out of Warner Bros (WBD) in Q4 2025, closing a stake of 1,655 shares — an estimated $32.3K sold.

Logan Capital Management first reported a position in WBD in Q1 2021 and held it in 18 quarters. The position peaked at $959K in Q2 2022. 1,313 funds tracked by Wall St. Rank hold WBD as of Q4 2025.

  • Logan Capital Management reported no remaining Warner Bros position as of Q4 2025 after selling out during the quarter.
  • Logan Capital Management sold 1,655 Warner Bros shares in Q4 2025, an estimated $32.3K.
  • Logan Capital Management first reported a position in Warner Bros in Q1 2021 and held it in 18 quarters.
  • Logan Capital Management's Warner Bros position peaked at $959K in Q2 2022.
  • 1,313 funds tracked by Wall St. Rank held Warner Bros as of Q4 2025.

Based on Logan Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.